Anticoagulation in Older Adults With Advanced Chronic Kidney Disease and Atrial Fibrillation: Comparative Safety of Apixaban, Rivaroxaban, and Warfarin
International Journal of Clinical Pharmacy and Medicine · 10.07.2026 · 1 (2)
DOI: 10.68760/ijcpm.2026.06 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical Pharmacy and Medicine, online erschienen am 10.07.2026. Verfasst von Mohamed Abdellatif.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Abdellatif, M. (2026). Anticoagulation in Older Adults With Advanced Chronic Kidney Disease and Atrial Fibrillation: Comparative Safety of Apixaban, Rivaroxaban, and Warfarin. International Journal of Clinical Pharmacy and Medicine, 1(2). https://doi.org/10.68760/ijcpm.2026.06
Vancouver
Abdellatif M. Anticoagulation in Older Adults With Advanced Chronic Kidney Disease and Atrial Fibrillation: Comparative Safety of Apixaban, Rivaroxaban, and Warfarin. International Journal of Clinical Pharmacy and Medicine. 2026;1(2). doi:10.68760/ijcpm.2026.06
BibTeX
@article{Abdellatif2026,
author = {Abdellatif, Mohamed},
title = {Anticoagulation in Older Adults With Advanced Chronic Kidney Disease and Atrial Fibrillation: Comparative Safety of Apixaban, Rivaroxaban, and Warfarin},
journal = {International Journal of Clinical Pharmacy and Medicine},
year = {2026},
volume = {1},
number = {2},
doi = {10.68760/ijcpm.2026.06}
}
EUVIMED